Peptok
peptides profiled research articles
Cognitive Enhancement

Dihexa

Formula: C24H38N4O5

P
Written by Peptok Research
Reviewed by Medical Advisory BoardLast updated: Jan 2026

Quick Stats

Evidence Strength2/10 (Low)

Based on number and quality of indexed studies

Community Popularity1/10 (Low)

Based on search volume and community interest

Legal Status

⚖️ Not FDA-approved or regulated

Type

Cognitive Enhancement

Route

Intranasal, Oral, Subcutaneous injection

Half-life

Not well characterized

Medical Disclaimer

This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.

Overview

Dihexa is a peptide under investigation for its potential cognitive enhancement properties. It's derived from Angiotensin IV and may improve memory and cognitive function by boosting **Hepatocyte Growth Factor (HGF)**, a key factor for brain health. Research is still preliminary, but promising.

Quick Summary

  • 🧬
    What it is:Dihexa is a peptide under investigation for its potential cognitive enhancement properties.
  • 🎯
    Primary use:Cognitive Enhancement applications — see benefits section for details.
  • 📊
    Evidence level:Preliminary — Mostly anecdotal or very early-stage research (2 indexed papers)
  • Bottom line:Very early research phase. Approach with appropriate caution; long-term safety is unknown.

Dihexa stands out because it's believed to enhance cognitive function through a unique mechanism: boosting the production of Hepatocyte Growth Factor (HGF), a protein crucial for brain development and repair. Unlike many nootropics that focus on neurotransmitter modulation, Dihexa targets the physical structure and resilience of brain cells.

How Dihexa Works

Dihexa's primary mechanism involves amplifying the activity of Hepatocyte Growth Factor (HGF). HGF is a growth factor that plays a vital role in the development, maintenance, and repair of various tissues, including the brain. It binds to the c-Met receptor, which is found on the surface of many cells, including neurons. When HGF binds to c-Met, it triggers a cascade of intracellular signaling events that promote cell survival, growth, and differentiation (J Alzheimers Dis. 2015;45(4):985-1000).

Specifically, Dihexa mimics the action of Angiotensin IV, a peptide fragment of angiotensinogen. Angiotensin IV is known to interact with HGF and enhance its activity. By mimicking this interaction, Dihexa can effectively amplify the HGF signaling pathway in the brain. This amplification can lead to several beneficial effects on cognitive function.

The HGF/c-Met system is critical for synaptogenesis, the formation of new connections between neurons. Stronger, more numerous synapses directly translate to improved learning and memory. By promoting synaptogenesis, Dihexa may enhance the brain's ability to form and retain new memories. HGF also protects neurons from damage and promotes their survival. This neuroprotective effect could be particularly beneficial in age-related cognitive decline and neurodegenerative diseases.

What the Research Actually Shows

Here's a breakdown of the research on Dihexa and its potential benefits:

  • Cognitive Enhancement: Research suggests that Dihexa may improve cognitive function, particularly in areas related to learning and memory. A systematic review of studies on Angiotensin IV and Angiotensin-(1-7) found cognitive benefits in experimental models (Neurosci Biobehav Rev. 2018 Sep;92:209-225). Evidence Grade: Animal Only
  • Alzheimer's Disease: Some studies have explored Dihexa's potential in treating Alzheimer's disease by targeting the HGF/c-Met receptor system (J Alzheimers Dis. 2015;45(4):985-1000). The development of small molecule angiotensin IV analogs has also been explored as a potential treatment for Alzheimer's and Parkinson's diseases (Prog Neurobiol. 2015 Feb;125:26-46). Evidence Grade: Animal Only
  • Neuroprotection: Dihexa may protect brain cells from damage. One study showed that a hepatocyte growth factor mimetic protected lateral line hair cells from aminoglycoside exposure (Front Cell Neurosci. 2015 Jan 28;9:3). While this study didn't directly use Dihexa, it supports the idea that HGF mimetics can have neuroprotective effects. Evidence Grade: Animal Only
  • Synaptogenesis: While direct studies on Dihexa and synaptogenesis in living organisms are limited, the established role of HGF in promoting synapse formation strongly suggests that Dihexa could enhance this process. Evidence Grade: Preliminary

It's important to note that much of the research on Dihexa is still in the early stages, with most studies being conducted on animals or in vitro. More research, especially human clinical trials, is needed to confirm these findings and determine the optimal dosage and safety profile of Dihexa.

Dihexa vs. P21

Both Dihexa and P21 are being researched for cognitive enhancement, but they work through different mechanisms. Dihexa boosts HGF and synaptogenesis, focusing on the structural health of neurons and their connections. P21, on the other hand, is a C-terminal fragment of the protein Basic Fibroblast Growth Factor (bFGF). It primarily targets neurite outgrowth, the extension of new projections from neurons, and neuroprotection.

Mechanistically, Dihexa enhances the HGF/c-Met signaling pathway, promoting cell survival, growth, and differentiation. P21, derived from bFGF, is believed to exert its effects by interacting with FGF receptors, leading to neurite outgrowth and neuroprotection. While both aim to improve cognitive function, Dihexa emphasizes synapse formation and strengthening existing connections, while P21 focuses more on growing new neuronal connections and protecting existing neurons from damage.

A key difference is the available research. Dihexa has some animal studies suggesting cognitive benefits and potential for treating Alzheimer's disease. P21 also has pre-clinical research indicating neuroprotective and cognitive-enhancing effects. However, neither peptide has extensive human clinical trials to definitively prove their efficacy and safety.

The Honest Limitations

The primary limitation of Dihexa research is the lack of human clinical trials. Most of the existing data comes from animal studies or in vitro experiments. This means that while the results are promising, we cannot definitively say whether Dihexa will have the same effects in humans.

Furthermore, the long-term effects of Dihexa are unknown. Most studies have only examined the short-term effects of the peptide. We don't know how Dihexa will affect the brain over extended periods of use.

Finally, the optimal dosage of Dihexa is still unclear. Animal studies have used varying doses, and it's not yet known what the ideal dosage is for humans. This makes it difficult to determine the most effective and safe way to use Dihexa.

Sourcing Considerations for Dihexa

Given the research stage of Dihexa, sourcing high-quality material is critical. Because it's not a regulated pharmaceutical, quality control can vary significantly between vendors. Here's what to consider:

  • Certificate of Analysis (COA): Always request a COA from the vendor. This document should verify the purity and identity of the Dihexa. Look for a COA from a third-party lab for unbiased results.
  • Purity Level: Aim for a purity level of at least 98%. Lower purity can mean the presence of unwanted byproducts.
  • Reputable Vendor: Research the vendor's reputation. Look for reviews and testimonials from other users. A vendor with a history of providing high-quality peptides is more likely to offer genuine Dihexa.
  • Storage Instructions: Follow the vendor's storage instructions carefully. Peptides are generally sensitive to heat, light, and moisture. Proper storage is essential to maintain the integrity of the compound. Typically, this means storing it in a cool, dark, and dry place, often in a freezer.
  • Research Purposes Only: Be aware that Dihexa is typically sold for research purposes only. This means it is not intended for human consumption and has not been evaluated for safety or efficacy in humans.
  • Cost: Be wary of extremely low prices, as this could indicate a low-quality or counterfeit product. High-quality peptides typically come at a premium.

Benefits & Evidence

Extremely potent cognitive enhancement

Moderate Evidence

2 studies · 0 human trials

Promotes new synaptic connections (synaptogenesis)

Preliminary

1 studies · 0 human trials

Memory formation and consolidation

Preliminary

1 studies · 0 human trials

Neuroprotection against neurodegenerative damage

Preliminary

1 studies · 0 human trials

10 million times more potent than BDNF

Preliminary

1 studies · 0 human trials

Improved learning capacity

Preliminary

1 studies · 0 human trials

Who Uses Dihexa?

Biohackers & nootropic users

Preliminary

Reported improvements in focus and mood

High-stress professionals

Preliminary

Potential anxiolytic and adaptogenic effects

Students & knowledge workers

Anecdotal

Memory and learning enhancement reported

Not recommended if:

Pregnant or nursing, history of hormone-sensitive cancers, active autoimmune conditions, or pediatric patients. Always consult a physician before starting any peptide protocol.

Dosage Guide

Protocol by Experience Level

ExperienceDoseFrequencyCycleRoute
Beginner5 mgDaily or EOD4–6 wks, 2 wks offOral
Intermediate13 mgDaily4–6 wks, 2 wks offOral
Advanced20 mgDaily (split dose)4–6 wks, 2 wks offOral

Standard Protocol

5-20 mg orally or 0.5-2 mg intranasally (community protocols — no clinical standard)

Notes

Extremely potent compound with very limited human data. No clinical trials in humans. All dosing is extrapolated from animal research. Use with extreme caution.

Route

Intranasal, Oral, Subcutaneous injection

Half-life

Not well characterized

Molecular Weight

462.58 g/mol

Disclaimer

This information is for educational purposes only. Dosage information is derived from research literature and community reports. Always consult a qualified healthcare provider before using any peptide.

What the Community Reports

Community data coming soon

We're aggregating Reddit discussions for Dihexa.

Safety Profile

Regulatory Status

Not FDA-approved or regulated. Available as research chemical. Very limited regulatory attention.

Common

  • Very limited safety data
  • Potential for excessive neural growth (theoretical concern)
  • Unknown long-term effects

Rare

  • Possible blood pressure effects (angiotensin-related)

Serious

No serious adverse events reported in available literature.

Pregnancy: ❌ Not recommended — no safety dataKnown Interactions: 3 documented stacks
Available

Your Ad could be placed here.

Reach researchers and enthusiasts.

Contact Us

Research

Mechanism of Action

Dihexa is a stable analog of angiotensin IV that activates the hepatocyte growth factor (HGF)/c-Met receptor system. It acts as an allosteric activator of HGF, dramatically enhancing its ability to bind c-Met receptors. This triggers prosurvival signaling cascades that promote dendritic spine formation, synaptogenesis, and neuronal survival. Its picomolar potency makes it orders of magnitude more effective than BDNF at driving new neural connections.

Search Volume Trend

Rank #22
12 months agoPresent
Animal Study2013

Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) enhances cognitive function in rats

Journal of Pharmacology and Experimental Therapeutics · McCoy AT, et al.

Animal Study2014

Hepatocyte growth factor mimetic as a therapeutic for dementia

Neurobiology of Aging · Benoist CC, et al.

Common Stacks

Peptides frequently combined together for synergistic effects.

Semax

Cognitive

Cognitive enhancement stack — anxiolytic + nootropic

Selank

Cognitive

Cognitive enhancement stack — anxiolytic + nootropic

P21

Performance

Commonly combined with P21 for enhanced outcomes

Peptok is editorially independent. Our research profiles are evidence-based and regularly updated. Sponsored content is always clearly labeled. Read our Editorial Policy.